RODMAN&RENSHAW upgraded shares of INmune Bio (NASDAQ:INMB – Free Report) to a strong-buy rating in a research note published on Tuesday morning,Zacks.com reports. Other equities analysts also recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback